Advent to sell stake in manufacturer and drug developer in a deal worth over $1B — report

After almost three years of investment, private equity firm Advent International may look to sell its part in Bioduro-Sundia.

A Reuters report on Monday detailed that Advent International plans to sell a majority stake in the manufacturing and drug development company that could value the company…